COHEN & STEERS INC (CNS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CNS - US19247A1007 - Common Stock
65.25 USD
-0.66 (-1%)
65.25 USD
0 (0%)
CNS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 237 industry peers in the Capital Markets industry. While CNS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CNS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- CNS had positive earnings in the past year.
- In the past year CNS has reported a negative cash flow from operations.
- In the past 5 years CNS has always been profitable.
- Of the past 5 years CNS 4 years had a positive operating cash flow.
1.2 Ratios
- CNS has a Return On Assets of 20.48%. This is amongst the best in the industry. CNS outperforms 97.47% of its industry peers.
- CNS has a better Return On Equity (29.83%) than 95.36% of its industry peers.
- CNS has a Return On Invested Capital of 24.42%. This is amongst the best in the industry. CNS outperforms 97.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.48% | ||
| ROE | 29.83% | ||
| ROIC | 24.42% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of CNS (29.73%) is better than 73.42% of its industry peers.
- In the last couple of years the Profit Margin of CNS has grown nicely.
- The Operating Margin of CNS (33.83%) is better than 64.98% of its industry peers.
- CNS's Operating Margin has declined in the last couple of years.
- The Gross Margin of CNS (88.60%) is better than 92.83% of its industry peers.
- In the last couple of years the Gross Margin of CNS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.83% | ||
| PM (TTM) | 29.73% | ||
| GM | 88.6% |
OM growth 3Y-4.66%
OM growth 5Y-2.01%
PM growth 3Y-3.48%
PM growth 5Y8.65%
GM growth 3Y0.67%
GM growth 5Y0.08%
2. Health
2.1 Basic Checks
- CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 9.23 indicates that CNS is not in any danger for bankruptcy at the moment.
- CNS's Altman-Z score of 9.23 is amongst the best of the industry. CNS outperforms 94.09% of its industry peers.
- There is no outstanding debt for CNS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 9.23 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- CNS has a Current Ratio of 0.79. This is a bad value and indicates that CNS is not financially healthy enough and could expect problems in meeting its short term obligations.
- CNS has a worse Current ratio (0.79) than 63.29% of its industry peers.
- A Quick Ratio of 0.79 indicates that CNS may have some problems paying its short term obligations.
- CNS has a worse Quick ratio (0.79) than 62.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
- CNS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.80%.
- CNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.74% yearly.
- CNS shows a small growth in Revenue. In the last year, the Revenue has grown by 7.04%.
- CNS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.73% yearly.
EPS 1Y (TTM)5.8%
EPS 3Y-5.81%
EPS 5Y3.74%
EPS Q2Q%3.85%
Revenue 1Y (TTM)7.04%
Revenue growth 3Y-0.12%
Revenue growth 5Y5.73%
Sales Q2Q%-5.55%
3.2 Future
- The Earnings Per Share is expected to grow by 8.66% on average over the next years. This is quite good.
- CNS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.70% yearly.
EPS Next Y8.49%
EPS Next 2Y8.3%
EPS Next 3Y8.22%
EPS Next 5Y8.66%
Revenue Next Year8.33%
Revenue Next 2Y7.78%
Revenue Next 3Y7.24%
Revenue Next 5Y6.7%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 21.05, the valuation of CNS can be described as rather expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of CNS indicates a slightly more expensive valuation: CNS is more expensive than 61.18% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of CNS to the average of the S&P500 Index (27.25), we can say CNS is valued slightly cheaper.
- A Price/Forward Earnings ratio of 19.40 indicates a rather expensive valuation of CNS.
- CNS's Price/Forward Earnings is on the same level as the industry average.
- CNS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 25.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.05 | ||
| Fwd PE | 19.4 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CNS is valued a bit cheaper than the industry average as 78.48% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.46 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- CNS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.48
PEG (5Y)5.63
EPS Next 2Y8.3%
EPS Next 3Y8.22%
5. Dividend
5.1 Amount
- CNS has a Yearly Dividend Yield of 3.76%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 5.87, CNS has a dividend in line with its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, CNS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
5.2 History
- The dividend of CNS decreases each year by -7.12%.
- CNS has paid a dividend for at least 10 years, which is a reliable track record.
- The dividend of CNS decreased in the last 3 years.
Dividend Growth(5Y)-7.12%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 76.25% of the earnings are spent on dividend by CNS. This is not a sustainable payout ratio.
DP76.25%
EPS Next 2Y8.3%
EPS Next 3Y8.22%
COHEN & STEERS INC / CNS FAQ
What is the ChartMill fundamental rating of COHEN & STEERS INC (CNS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CNS.
What is the valuation status for CNS stock?
ChartMill assigns a valuation rating of 2 / 10 to COHEN & STEERS INC (CNS). This can be considered as Overvalued.
Can you provide the profitability details for COHEN & STEERS INC?
COHEN & STEERS INC (CNS) has a profitability rating of 7 / 10.
Can you provide the financial health for CNS stock?
The financial health rating of COHEN & STEERS INC (CNS) is 5 / 10.
What is the expected EPS growth for COHEN & STEERS INC (CNS) stock?
The Earnings per Share (EPS) of COHEN & STEERS INC (CNS) is expected to grow by 8.49% in the next year.